Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes
•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity. Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesi...
Gespeichert in:
Veröffentlicht in: | Neuroscience 2016-06, Vol.324, p.485-495 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 495 |
---|---|
container_issue | |
container_start_page | 485 |
container_title | Neuroscience |
container_volume | 324 |
creator | Martins, D.F Turnes, B.L Cidral-Filho, F.J Bobinski, F Rosas, R.F Danielski, L.G Petronilho, F Santos, A.R.S |
description | •LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity.
Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology. |
doi_str_mv | 10.1016/j.neuroscience.2016.03.035 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1787976498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306452216300057</els_id><sourcerecordid>1783339787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</originalsourceid><addsrcrecordid>eNqNUsFq3DAQFaUl2Sb5hSJ66sVbybItO4dCSZO2sFBok7PQSqNEG1tyJLnE_frI7KaUniJGDEhv3gzzHkLvKVlTQpuPu7WDKfioLDgF6zK_rQnLUb9CK9pyVvC6ql6jFWGkKaq6LI_R2xh3JJ-6YkfouOSEUMq7FXrY2Nu7VMBgU7LuFmvrNeB0B0GOMw6gJwURjxCijQlcwtaZXg6DTD7MeJTWneOfvgfsTf5KEHqY7q3DlGDpdL7J-kerc8bg_swDxFP0xsg-wtkhn6Cbq8vri2_F5sfX7xefN4WqmjYVW0MrqVkFxsi2KaWpiexUS6niW9lpQw3ncstkzVWrZGs6TRilZdN0RnOAmp2gD3veMfiHCWISg40K-l468FMUlLe8403VtS-BMsa6XJCh53uoygLEAEaMwQ4yzIISsagjduJfdcSijiAsxzLSu0OfaTuA_lv6LEcGfNkDIC_mt4UgDjTaBlBJaG9f1ufTfzSqt84q2d_DDHHnp-Dy6gUVsRRE_Fp8stiENmyxCGdPTYO_PQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1783339787</pqid></control><display><type>article</type><title>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Martins, D.F ; Turnes, B.L ; Cidral-Filho, F.J ; Bobinski, F ; Rosas, R.F ; Danielski, L.G ; Petronilho, F ; Santos, A.R.S</creator><creatorcontrib>Martins, D.F ; Turnes, B.L ; Cidral-Filho, F.J ; Bobinski, F ; Rosas, R.F ; Danielski, L.G ; Petronilho, F ; Santos, A.R.S</creatorcontrib><description>•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity.
Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/j.neuroscience.2016.03.035</identifier><identifier>PMID: 27001179</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Antioxidants - metabolism ; Catalase - metabolism ; Disease Models, Animal ; Freund's Adjuvant ; Hot Temperature ; Hyperalgesia - metabolism ; Hyperalgesia - therapy ; inflammation ; Inflammation - metabolism ; Inflammation - therapy ; Interleukin-10 - metabolism ; Interleukin-1beta - metabolism ; low-level light therapy ; Male ; Mice ; Neurology ; Oxidative Stress - physiology ; Pain - metabolism ; Pain Management - instrumentation ; Pain Management - methods ; persistent pain ; Phototherapy - instrumentation ; Phototherapy - methods ; Superoxide Dismutase - metabolism ; Thiobarbituric Acid Reactive Substances - metabolism ; Touch ; Treatment Outcome ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Neuroscience, 2016-06, Vol.324, p.485-495</ispartof><rights>2016 IBRO</rights><rights>Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</citedby><cites>FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306452216300057$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27001179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martins, D.F</creatorcontrib><creatorcontrib>Turnes, B.L</creatorcontrib><creatorcontrib>Cidral-Filho, F.J</creatorcontrib><creatorcontrib>Bobinski, F</creatorcontrib><creatorcontrib>Rosas, R.F</creatorcontrib><creatorcontrib>Danielski, L.G</creatorcontrib><creatorcontrib>Petronilho, F</creatorcontrib><creatorcontrib>Santos, A.R.S</creatorcontrib><title>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity.
Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.</description><subject>Animals</subject><subject>Antioxidants - metabolism</subject><subject>Catalase - metabolism</subject><subject>Disease Models, Animal</subject><subject>Freund's Adjuvant</subject><subject>Hot Temperature</subject><subject>Hyperalgesia - metabolism</subject><subject>Hyperalgesia - therapy</subject><subject>inflammation</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - therapy</subject><subject>Interleukin-10 - metabolism</subject><subject>Interleukin-1beta - metabolism</subject><subject>low-level light therapy</subject><subject>Male</subject><subject>Mice</subject><subject>Neurology</subject><subject>Oxidative Stress - physiology</subject><subject>Pain - metabolism</subject><subject>Pain Management - instrumentation</subject><subject>Pain Management - methods</subject><subject>persistent pain</subject><subject>Phototherapy - instrumentation</subject><subject>Phototherapy - methods</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Thiobarbituric Acid Reactive Substances - metabolism</subject><subject>Touch</subject><subject>Treatment Outcome</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsFq3DAQFaUl2Sb5hSJ66sVbybItO4dCSZO2sFBok7PQSqNEG1tyJLnE_frI7KaUniJGDEhv3gzzHkLvKVlTQpuPu7WDKfioLDgF6zK_rQnLUb9CK9pyVvC6ql6jFWGkKaq6LI_R2xh3JJ-6YkfouOSEUMq7FXrY2Nu7VMBgU7LuFmvrNeB0B0GOMw6gJwURjxCijQlcwtaZXg6DTD7MeJTWneOfvgfsTf5KEHqY7q3DlGDpdL7J-kerc8bg_swDxFP0xsg-wtkhn6Cbq8vri2_F5sfX7xefN4WqmjYVW0MrqVkFxsi2KaWpiexUS6niW9lpQw3ncstkzVWrZGs6TRilZdN0RnOAmp2gD3veMfiHCWISg40K-l468FMUlLe8403VtS-BMsa6XJCh53uoygLEAEaMwQ4yzIISsagjduJfdcSijiAsxzLSu0OfaTuA_lv6LEcGfNkDIC_mt4UgDjTaBlBJaG9f1ufTfzSqt84q2d_DDHHnp-Dy6gUVsRRE_Fp8stiENmyxCGdPTYO_PQ</recordid><startdate>20160602</startdate><enddate>20160602</enddate><creator>Martins, D.F</creator><creator>Turnes, B.L</creator><creator>Cidral-Filho, F.J</creator><creator>Bobinski, F</creator><creator>Rosas, R.F</creator><creator>Danielski, L.G</creator><creator>Petronilho, F</creator><creator>Santos, A.R.S</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope></search><sort><creationdate>20160602</creationdate><title>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</title><author>Martins, D.F ; Turnes, B.L ; Cidral-Filho, F.J ; Bobinski, F ; Rosas, R.F ; Danielski, L.G ; Petronilho, F ; Santos, A.R.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-bf14ad34effa862af50a9c811c7ba9df1f77ab3a57c8ca8f9d03112669fd7ee53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antioxidants - metabolism</topic><topic>Catalase - metabolism</topic><topic>Disease Models, Animal</topic><topic>Freund's Adjuvant</topic><topic>Hot Temperature</topic><topic>Hyperalgesia - metabolism</topic><topic>Hyperalgesia - therapy</topic><topic>inflammation</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - therapy</topic><topic>Interleukin-10 - metabolism</topic><topic>Interleukin-1beta - metabolism</topic><topic>low-level light therapy</topic><topic>Male</topic><topic>Mice</topic><topic>Neurology</topic><topic>Oxidative Stress - physiology</topic><topic>Pain - metabolism</topic><topic>Pain Management - instrumentation</topic><topic>Pain Management - methods</topic><topic>persistent pain</topic><topic>Phototherapy - instrumentation</topic><topic>Phototherapy - methods</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Thiobarbituric Acid Reactive Substances - metabolism</topic><topic>Touch</topic><topic>Treatment Outcome</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martins, D.F</creatorcontrib><creatorcontrib>Turnes, B.L</creatorcontrib><creatorcontrib>Cidral-Filho, F.J</creatorcontrib><creatorcontrib>Bobinski, F</creatorcontrib><creatorcontrib>Rosas, R.F</creatorcontrib><creatorcontrib>Danielski, L.G</creatorcontrib><creatorcontrib>Petronilho, F</creatorcontrib><creatorcontrib>Santos, A.R.S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martins, D.F</au><au>Turnes, B.L</au><au>Cidral-Filho, F.J</au><au>Bobinski, F</au><au>Rosas, R.F</au><au>Danielski, L.G</au><au>Petronilho, F</au><au>Santos, A.R.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2016-06-02</date><risdate>2016</risdate><volume>324</volume><spage>485</spage><epage>495</epage><pages>485-495</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><abstract>•LEDT inhibited mechanical and thermal hiperalgesia.•LEDT increased the levels of IL-10.•LEDT induced an increase in both SOD and CAT activity.
Background: During the last decades, the use of light-emitting diode therapy (LEDT) has increased significantly for the treatment of wound healing, analgesia and inflammatory processes. Nevertheless, scientific data on the mechanisms responsible for the therapeutic effect of LEDT are still insufficient. Thus, this study investigated the analgesic, anti-inflammatory and anti-oxidative effect of LEDT in the model of chronic inflammatory hyperalgesia. Experimental procedures: Mice injected with Complete Freund’s Adjuvant (CFA) underwent behavioral, i.e. mechanical and hot hyperalgesia; determination of cytokine levels (tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), IL-10), oxidative stress markers (protein carbonyls and thiobarbituric acid reactive species (TBARS)) and antioxidant enzymes (catalase (CAT) and superoxide dismutase (SOD)). Additionally, mice were pretreated with either naloxone or fucoidin and mechanical hyperalgesia was assessed. Results: LEDT inhibited mechanical and thermal hyperalgesia induced by CFA injection. LEDT did not reduce paw edema, neither influenced the levels of TNF-α and IL1-β; although it increased the levels of IL-10. LEDT significantly prevented TBARS increase in both acute and chronic phases post-CFA injection; whereas protein carbonyl levels were reduced only in the acute phase. LEDT induced an increase in both SOD and CAT activity, with effects observable in the acute but not in the chronic. And finally, pre-administration of naloxone or fucoidin prevented LEDT analgesic effect. Conclusions: These data contribute to the understanding of the neurobiological mechanisms involved in the therapeutic effect of LEDT as well as provides additional support for its use in the treatment of painful conditions of inflammatory etiology.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>27001179</pmid><doi>10.1016/j.neuroscience.2016.03.035</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-4522 |
ispartof | Neuroscience, 2016-06, Vol.324, p.485-495 |
issn | 0306-4522 1873-7544 |
language | eng |
recordid | cdi_proquest_miscellaneous_1787976498 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Antioxidants - metabolism Catalase - metabolism Disease Models, Animal Freund's Adjuvant Hot Temperature Hyperalgesia - metabolism Hyperalgesia - therapy inflammation Inflammation - metabolism Inflammation - therapy Interleukin-10 - metabolism Interleukin-1beta - metabolism low-level light therapy Male Mice Neurology Oxidative Stress - physiology Pain - metabolism Pain Management - instrumentation Pain Management - methods persistent pain Phototherapy - instrumentation Phototherapy - methods Superoxide Dismutase - metabolism Thiobarbituric Acid Reactive Substances - metabolism Touch Treatment Outcome Tumor Necrosis Factor-alpha - metabolism |
title | Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T10%3A40%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Light-emitting%20diode%20therapy%20reduces%20persistent%20inflammatory%20pain:%20Role%20of%20interleukin%2010%20and%20antioxidant%20enzymes&rft.jtitle=Neuroscience&rft.au=Martins,%20D.F&rft.date=2016-06-02&rft.volume=324&rft.spage=485&rft.epage=495&rft.pages=485-495&rft.issn=0306-4522&rft.eissn=1873-7544&rft_id=info:doi/10.1016/j.neuroscience.2016.03.035&rft_dat=%3Cproquest_cross%3E1783339787%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1783339787&rft_id=info:pmid/27001179&rft_els_id=S0306452216300057&rfr_iscdi=true |